SCHEMBL21160375

SCHEMBL21160375

N/C=C\C=C/Cc1ccccn1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH1 P35367 2/20 0.46
LMNA P02545 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.40
MAPT P10636 1/20 0.40
LIN28A Q9H9Z2 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
GRIN2D O15399 1/20 0.40
GRIN3B O60391 1/20 0.40
GRIN1 Q05586 1/20 0.40
GRIN2A Q12879 1/20 0.40
GRIN2B Q13224 1/20 0.40
GRIN2C Q14957 1/20 0.40
GRIN3A Q8TCU5 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
MAOA P21397 2/20 0.38
MAOB P27338 2/20 0.38
HRH3 Q9Y5N1 1/20 0.38
PARP10 Q53GL7 1/20 0.37
TAAR1 Q96RJ0 1/20 0.37
ALDH1A1 P00352 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6428024 0.86 HRH1 (0.50) HRH1LMNASMN1; SMN2MAPTLIN28A
SCHEMBL248607 0.86 HRH1 (0.50) HRH1LMNASMN1; SMN2MAPTLIN28A
SCHEMBL18751372 0.81 HRH3 (0.42) HRH1LMNASMN1; SMN2MAPTLIN28A
SCHEMBL11800372 0.79 HRH1 (0.42) HRH1LMNASMN1; SMN2MAPTLIN28A
SCHEMBL21386868 0.79 HRH1 (0.42) HRH1LMNASMN1; SMN2MAPTLIN28A
SCHEMBL11815522 0.79 ALDH1A1 (0.44) HRH1LMNASMN1; SMN2MAPTLIN28A
SCHEMBL28985167 0.79 HRH1 (0.50) HRH1LMNASMN1; SMN2MAPTLIN28A
SCHEMBL28985180 0.79 HRH1 (0.50) HRH1LMNASMN1; SMN2MAPTLIN28A
SCHEMBL10810253 0.79 HRH1 (0.50) HRH1LMNASMN1; SMN2MAPTLIN28A
SCHEMBL6666747 0.78

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019136298-A1 COMPOUNDS, COMPOSITIONS, AND METHODS FOR TREATMENT OF DISEASES INVOLVING ACIDIC OR HYPOXIC DISEASED TISSUES Cybrexa, Inc. (US) 2019-07-11 WO disclosed